We are pleased to let you know that we are developing several monoclonal antibodies specific to SARS-CoV2 nucleoproteins (Cat.# 3CV4) and to Spike RBD (Cat.# 3CV2). The antibodies have been tested with COVID-19 positive patient samples.

Limited amounts of R&D samples are available, please inquire below:

See all our COVID-19 Products

Terms: The sample opportunity is only available to end users. Distributors and re-sellers are not included in this promotion. The usual shipping and handling costs will still apply. The sample opportunity is a one-time evaluation possibility and you can get more details by contacting HyTest customer service.